Literature DB >> 2218590

Limb shortening secondary to complications of vascular cannulae in the neonatal period.

R L Guy1, J P Holland, D G Shaw, J A Fixsen.   

Abstract

Four cases of limb shortening presenting in childhood are described. All four children had been managed in a neonatal intensive care unit and had developed complications following the insertion of intravascular cannulae. In two, lower limb shortening and deformity were secondary to direct epiphyseal damage following extravasation of calcium or dextrose from a peripheral venous line. In the other two, forearm shortening followed ischaemia, secondary to either radial artery thrombosis from a radial artery cannula or spasm of the brachial artery following extravasation from a venous cannula in a neonate who also had a radial artery cannula. These cases highlight an important complication of the use of vascular cannulae in neonates and the problems this may pose to the orthopaedic surgeon.

Entities:  

Mesh:

Year:  1990        PMID: 2218590     DOI: 10.1007/bf00241795

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  5 in total

1.  Complications during and following radial artery cannulation: a prospective study.

Authors:  B M Weiss; R I Gattiker
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

2.  Traumatic cupping of the metaphyses of growing bones.

Authors:  J Caffey
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1970-03

3.  Acquired bone dysplasia secondary to catheter-related complications in the neonate.

Authors:  J J Seibert; R E McCarthy; J E Alexander; B J Taylor; R W Seibert
Journal:  Pediatr Radiol       Date:  1986

4.  Complications from intravascular catheters. Primum non nocere.

Authors:  B C Morgan
Journal:  Am J Dis Child       Date:  1984-05

5.  Extremity amputation following radial artery cannulation in a patient with hyperlipoproteinemia type V.

Authors:  B W Cannon; W T Meshier
Journal:  Anesthesiology       Date:  1982-03       Impact factor: 7.892

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.